TY - JOUR
T1 - One-year readmission and mortality following ischaemic stroke by diabetes status, sex, and socioeconomic disadvantage
T2 - An analysis of 27,802 strokes from 2012 to 2017
AU - Morton, Jedidiah I.
AU - Ilomäki, Jenni
AU - Wood, Stephen J.
AU - Bell, J. Simon
AU - Shaw, Jonathan E.
AU - Magliano, Dianna J.
N1 - Funding Information:
J.I.M is supported by an Australian Government Research Training Program (RTP) Scholarship and Monash Graduate Excellence Scholarship. DJM is supported by a National Health and Medical Research Council Senior Research Fellowship. JES is supported by a National Health and Medical Research Council Investigator Grant. This work is partially supported by the Victorian Government's Operational Infrastructure Support Program.The authors would like to acknowledge the Victorian Department of Health as the source of VAED data for this study, and the Centre for Victorian Data Linkage (Victorian Department of Health) for the provision of data linkage.
Funding Information:
JI has consulted for AstraZeneca Australia and Amgen. JSB has received research grant funding paid to his employer from National Health and Medical Research Council, Victorian Government Department of Health, Dementia Australia Research Foundation, Yulgilbar Foundation, Dementia Centre for Research Collaboration, Aged Care Quality and Safety Commission, GlaxoSmithKline Supported Studies Programme, and aged care provider organisations unrelated to this work. JES has received honoraria from: Astra Zeneca, Sanofi, Novo Nordisk, MSD; Eli Lilly, Abbott, Mylan and Boehringer Ingelheim.
Funding Information:
J.I.M is supported by an Australian Government Research Training Program (RTP) Scholarship and Monash Graduate Excellence Scholarship . DJM is supported by a National Health and Medical Research Council Senior Research Fellowship. JES is supported by a National Health and Medical Research Council Investigator Grant . This work is partially supported by the Victorian Government's Operational Infrastructure Support Program .
Publisher Copyright:
© 2022 Elsevier B.V.
PY - 2022/3/15
Y1 - 2022/3/15
N2 - Objective: We estimated the 1-year incidence of readmission to hospital and 1-year all-cause mortality following ischaemic stroke (IS), by diabetes status, sex, and socioeconomic disadvantage. Methods: This study included all individuals aged ≥30 years who were discharged from hospital following an IS between July 2012 and June 2017 in Victoria, Australia (n = 25,421). Individuals were followed from discharge until readmission (for all-causes, cardiovascular readmission, and readmission for IS) or death, censoring at 1-year of follow-up. Results: The 1-year cumulative incidence of all-cause readmission following an IS was 56.1% (95% CI: 55.5–56.7); 24% of first all-cause admission were attributed to cardiovascular disease. People with diabetes were at an excess risk of all-cause, cardiovascular, and IS readmission following an IS (adjusted sub-HRs: 1.13 [95% CI: 1.09–1.17], 1.14 [1.07–1.21], and 1.17 [1.06–1.29], for people with vs. without diabetes, respectively) and 1-year mortality (adjusted HR: 1.11 [1.03–1.19]). There was no significant difference between men and women in all-cause and cardiovascular readmission risk, while women were at higher risk of IS readmission (sub-HR: 1.10 [1.01–1.21] for women vs. men) and mortality (HR: 1.12 [1.05–1.20]). There was no relationship between socioeconomic disadvantage and risk of cardiovascular or IS readmission, while 1-year mortality risk did increase with increasing socioeconomic disadvantage (HR for most vs. least disadvantaged quintile: 1.15 [1.03–1.27]; ptrend = 0.006), and all-cause readmission risk decreased (sub-HR: 0.94 [0.90–0.99]; ptrend = 0.001). Conclusions: There is a high risk of readmission following IS. Decreasing the readmission rate will require more complex interventions than solely improving post-discharge cardiovascular management.
AB - Objective: We estimated the 1-year incidence of readmission to hospital and 1-year all-cause mortality following ischaemic stroke (IS), by diabetes status, sex, and socioeconomic disadvantage. Methods: This study included all individuals aged ≥30 years who were discharged from hospital following an IS between July 2012 and June 2017 in Victoria, Australia (n = 25,421). Individuals were followed from discharge until readmission (for all-causes, cardiovascular readmission, and readmission for IS) or death, censoring at 1-year of follow-up. Results: The 1-year cumulative incidence of all-cause readmission following an IS was 56.1% (95% CI: 55.5–56.7); 24% of first all-cause admission were attributed to cardiovascular disease. People with diabetes were at an excess risk of all-cause, cardiovascular, and IS readmission following an IS (adjusted sub-HRs: 1.13 [95% CI: 1.09–1.17], 1.14 [1.07–1.21], and 1.17 [1.06–1.29], for people with vs. without diabetes, respectively) and 1-year mortality (adjusted HR: 1.11 [1.03–1.19]). There was no significant difference between men and women in all-cause and cardiovascular readmission risk, while women were at higher risk of IS readmission (sub-HR: 1.10 [1.01–1.21] for women vs. men) and mortality (HR: 1.12 [1.05–1.20]). There was no relationship between socioeconomic disadvantage and risk of cardiovascular or IS readmission, while 1-year mortality risk did increase with increasing socioeconomic disadvantage (HR for most vs. least disadvantaged quintile: 1.15 [1.03–1.27]; ptrend = 0.006), and all-cause readmission risk decreased (sub-HR: 0.94 [0.90–0.99]; ptrend = 0.001). Conclusions: There is a high risk of readmission following IS. Decreasing the readmission rate will require more complex interventions than solely improving post-discharge cardiovascular management.
KW - Healthcare systems
KW - Ischaemic stroke
KW - Social determinants of health
KW - Type 2 diabetes mellitus
UR - https://www.scopus.com/pages/publications/85122961508
U2 - 10.1016/j.jns.2022.120149
DO - 10.1016/j.jns.2022.120149
M3 - Article
C2 - 35065425
AN - SCOPUS:85122961508
SN - 0022-510X
VL - 434
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
M1 - 120149
ER -